Gwen A. Fyfe

This profile gathers the share dealings of Gwen A. Fyfe across 2 companies, led by Array Biopharma Inc and Cascadian Therapeutics, Inc. Between 29 October 2016 and 30 July 2019, the trades on record add up to 9 filings.

Every open-market trade on record is a purchase: 1 purchase worth €6,345, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 4 option exercises.

The record was last updated on 30 July 2019 with a transaction in Array Biopharma Inc. The latest purchase dates back some time: it was published 3,492 days ago, on 30 March 2017. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.